Watson news

Watson's Trelstar NDA accepted for filing by FDA

Trading Markets (press release) - 34 minutes ago
Nov 17 , 2008 ( Datamonitor via COMTEX ) - - WPI | Quote | Chart | News | PowerRating - - Watson Pharmaceuticals , a specialty pharmaceutical company , has announced that its new drug application ...

Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer

Watson Pharmaceuticals, Inc. - SWOT Analysis - New Research Report on Companies and Markets

Watson Announces the NDA for a 6-Month Formulation of Trelstar Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer

FDA to review Watson's longer-lasting cancer drug

Forbes - 1 hour ago
AP , 11.13 . 08 , 06 : 28 PM ESTWatson Pharmaceuticals said federal health officials should make a decision on a long - lasting version of its prostate cancer drug Trelstar by third quarter 2009.The ...

Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer

FDA to review Watson's longer-lasting cancer drug

CNNMoney.com - 27 minutes ago
NEW YORK ( Associated Press ) - Watson Pharmaceuticals said federal health officials should make a decision on a long - lasting version of its prostate cancer drug Trelstar by third quarter 2009.The ...

Watson Pharma says FDA accepts NDA for prostrate cancer drug TRELSTAR - Quick Facts

Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer

Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer